JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

Search

Phibro Animal Health Corp

Gesloten

SectorGezondheidszorg

26.6 -1.74

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

26.41

Max

26.98

Belangrijke statistieken

By Trading Economics

Inkomsten

18M

21M

Verkoop

39M

348M

K/W

Sectorgemiddelde

34.795

34.393

Dividendrendement

1.84

Winstmarge

6.003

Werknemers

1,940

EBITDA

26M

51M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-4.2% downside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.84%

2.54%

Volgende Winsten

27 aug 2025

Volgende dividenddatum

24 sep 2025

Volgende Ex Dividend datum

3 sep 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

107M

1.1B

Vorige openingsprijs

28.34

Vorige sluitingsprijs

26.6

Nieuwssentiment

By Acuity

50%

50%

176 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Phibro Animal Health Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 aug 2025, 23:11 UTC

Winsten

Australia's REA Hikes Dividend as Annual Profit Rises 23% -- Update

5 aug 2025, 22:45 UTC

Winsten

Australia's REA Hikes Dividend as Annual Profit Rises 23%

5 aug 2025, 22:39 UTC

Winsten

Great-West Lifeco Logs Lower 2Q Profit

5 aug 2025, 21:32 UTC

Winsten

Coupang Posts Higher 2Q Sales Due to Customer Growth

6 aug 2025, 00:00 UTC

Acquisities, Fusies, Overnames

NFL to Take 10% Stake in Disney's ESPN -- WSJ

6 aug 2025, 00:00 UTC

Acquisities, Fusies, Overnames

The NFL Is Taking a 10% Stake in Disney's ESPN -- WSJ

6 aug 2025, 00:00 UTC

Acquisities, Fusies, Overnames

Disney to Take Control of NFL Network as Part of Agreement -- WSJ

6 aug 2025, 00:00 UTC

Acquisities, Fusies, Overnames

Disney, NFL Strike Wide-Reaching Media-Asset Deal -- WSJ

5 aug 2025, 23:48 UTC

Marktinformatie

Nikkei May Decline Amid U.S. Economic Uncertainty -- Market Talk

5 aug 2025, 23:40 UTC

Marktinformatie

Gold Edges Higher, Supported by Fed Rate-Cut Hopes -- Market Talk

5 aug 2025, 23:19 UTC

Marktinformatie

Lindian Deal With Iluka Demonstrates Kangankunde Project Appeal -- Market Talk

5 aug 2025, 23:03 UTC

Marktinformatie
Winsten

Advanced Micro Devices' Data-Center Story Seen as Promising -- Market Talk

5 aug 2025, 22:22 UTC

Winsten

REA: Expectation of More Interest-Rate Cuts Likely to Support Buyer Demand>REA.AU

5 aug 2025, 22:21 UTC

Winsten

REA Expects FY26 Listing Volumes Broadly Flat on FY25>REA.AU

5 aug 2025, 22:20 UTC

Winsten

REA Expects September-Quarter Listings to Be Down on Year>REA.AU

5 aug 2025, 22:18 UTC

Winsten

REA July 2025 New Residential Listings Down 8% on Year>REA.AU

5 aug 2025, 22:17 UTC

Winsten

REA FY25 Australian Residential Listings Up 1% on Year>REA.AU

5 aug 2025, 22:17 UTC

Winsten

REA FY25 India Revenue A$129M Vs. A$103M>REA.AU

5 aug 2025, 22:16 UTC

Winsten

REA FY25 Core Australia Revenue A$1.54B Vs. A$1.35B>REA.AU

5 aug 2025, 22:16 UTC

Winsten

REA FY25 Core Operations Net Profit A$564.4M Vs. A$460.5M>REA.AU

5 aug 2025, 22:15 UTC

Winsten

REA Group FY25 Ebitda A$969.2M Vs. A$824.8M>REA.AU

5 aug 2025, 22:13 UTC

Winsten

REA Group Raises Dividend to A$1.38 Vs. A$1.02 >REA.AU

5 aug 2025, 22:13 UTC

Winsten

REA Group FY25 Rev A$1.67B Vs. A$1.45B >REA.AU

5 aug 2025, 22:12 UTC

Winsten

REA FY25 Core Operations Net Profit A$564.4M Vs, A$460.5M>REA.AU

5 aug 2025, 22:12 UTC

Winsten

REA Group FY25 Net A$677.9M Vs. Net A$302.8M >REA.AU

5 aug 2025, 21:58 UTC

Winsten

Novo Nordisk's Earnings Come After a Dramatic Guidance Cut. What to Look for Now. -- Barrons.com

5 aug 2025, 21:30 UTC

Winsten

AMD Gives a Strong Outlook. Why the Stock Is Falling. -- Barrons.com

5 aug 2025, 21:26 UTC

Winsten

AMD CEO Expects Embedded Segment to Return to Sequential Growth in Back Half of 2025

5 aug 2025, 21:23 UTC

Winsten

AMD CEO Sees Strong Customer Interest in MI400 Series for Large-Scale Deployments

5 aug 2025, 21:17 UTC

Winsten

AMD Expects Steep Production Ramp for MI350 Series in Back Half of Year, CEO Says

Peer Vergelijking

Prijswijziging

Phibro Animal Health Corp Prognose

Koersdoel

By TipRanks

-4.2% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 26 USD  -4.2%

Hoogste 35 USD

Laagste 19 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Phibro Animal Health Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

4 ratings

1

Buy

2

Hold

1

Sell

Technische score

By Trading Central

17 / N/ASteun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

176 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.